Michael A. Hollingsworth - Publications

University of Nebraska Medical Center, Omaha, NE, United States 

224 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Saxena S, Prajapati DR, Goel P, Tomar B, Hayashi Y, Atri P, Rachagani S, Grandgenett PM, Hollingsworth MA, Batra SK, Singh RK. Plexin-B3 Regulates Cellular Motility, Invasiveness, and Metastasis in Pancreatic Cancer. Cancers. 13. PMID 33669221 DOI: 10.3390/cancers13040818  0.44
2021 Sagar S, Leiphrakpam PD, Thomas D, McAndrews KL, Caffrey TC, Swanson BJ, Clausen H, Wandall HH, Hollingsworth MA, Radhakrishnan P. MUC4 enhances gemcitabine resistance and malignant behaviour in pancreatic cancer cells expressing cancer-associated short O-glycans. Cancer Letters. PMID 33485947 DOI: 10.1016/j.canlet.2021.01.015  0.92
2020 Thomas D, Sagar S, Liu X, Lee HR, Grunkemeyer JA, Grandgenett PM, Caffrey T, O'Connell KA, Swanson B, Marcos-Silva L, Steentoft C, Wandall HH, Maurer HC, Peng XL, Yeh JJ, ... ... Hollingsworth MA, et al. Isoforms of MUC16 Activate Oncogenic Signaling Through EGF Receptors to Enhance the Progression of Pancreatic Cancer. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 33359791 DOI: 10.1016/j.ymthe.2020.12.029  0.44
2020 Nimmakayala RK, Leon F, Rachagani S, Rauth S, Nallasamy P, Marimuthu S, Shailendra GK, Chhonker YS, Chugh S, Chirravuri R, Gupta R, Mallya K, Prajapati DR, Lele SM, C Caffrey T, ... ... Hollingsworth MA, et al. Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma. Oncogene. PMID 33110235 DOI: 10.1038/s41388-020-01518-2  0.44
2020 Young ED, Manley SJ, Beadnell TC, Shearin AE, Sasaki K, Zimmerman R, Kauffman E, Vivian CJ, Parasuram A, Iwakuma T, Grandgenett PM, Hollingsworth MA, O'Neil M, Welch DR. Suppression of pancreatic cancer liver metastasis by secretion-deficient ITIH5. British Journal of Cancer. PMID 33024269 DOI: 10.1038/s41416-020-01093-z  0.44
2020 Lenkiewicz E, Malasi S, Hogenson TL, Flores LF, Barham W, Phillips WJ, Roesler AS, Chambers KR, Rajbhandari N, Hayashi A, Grandgenett PM, Hollingsworth MA, Cridebring D, Xiong Y, Lee JH, et al. Genomic and Epigenomic Landscaping Defines New Therapeutic Targets for Adenosquamous Carcinoma of the Pancreas. Cancer Research. PMID 32928922 DOI: 10.1158/0008-5472.Can-20-0078  0.44
2020 Hoshino A, Kim HS, Bojmar L, Gyan KE, Cioffi M, Hernandez J, Zambirinis CP, Rodrigues G, Molina H, Heissel S, Mark MT, Steiner L, Benito-Martin A, Lucotti S, Di Giannatale A, ... ... Hollingsworth MA, et al. Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers. Cell. PMID 32795414 DOI: 10.1016/J.Cell.2020.07.009  0.64
2020 Mundry C, Eberle KC, Singh PK, Hollingsworth MA, Mehla K. Local and systemic immunosuppression in pancreatic cancer: Targeting the stalwarts in tumor's arsenal. Biochimica Et Biophysica Acta. Reviews On Cancer. 188387. PMID 32579889 DOI: 10.1016/j.bbcan.2020.188387  0.84
2020 Dasgupta A, Shukla SK, Vernucci E, King RJ, Abrego J, Mulder SE, Mullen NJ, Graves G, Buettner K, Thakur R, Murthy D, Attri KS, Wang D, Chaika NV, Pacheco CG, ... ... Hollingsworth MA, et al. SIRT1-NOX4 signaling axis regulates cancer cachexia. The Journal of Experimental Medicine. 217. PMID 32441762 DOI: 10.1084/Jem.20190745  0.84
2020 Olson MT, Wojtynek NE, Talmon GA, Caffrey TC, Radhakrishnan P, Ly QP, Hollingsworth MA, Mohs AM. Development of a MUC16-Targeted Near-Infrared Fluorescent Antibody Conjugate for Intraoperative Imaging of Pancreatic Cancer. Molecular Cancer Therapeutics. PMID 32404409 DOI: 10.1158/1535-7163.MCT-20-0033  0.56
2020 Shukla SK, Markov SD, Attri KS, Vernucci E, King RJ, Dasgupta A, Grandgenett PM, Hollingsworth MA, Singh PK, Yu F, Mehla K. Macrophages potentiate STAT3 signaling in skeletal muscles and regulate pancreatic cancer cachexia. Cancer Letters. PMID 32344015 DOI: 10.1016/j.canlet.2020.04.017  0.84
2020 Shin SC, Thomas D, Radhakrishnan P, Hollingsworth MA. Invasive phenotype induced by low extracellular pH requires mitochondria dependent metabolic flexibility. Biochemical and Biophysical Research Communications. PMID 32081432 DOI: 10.1016/j.bbrc.2020.02.018  0.4
2020 Yokoyama S, Hamada T, Higashi M, Matsuo K, Maemura K, Kurahara H, Horinouchi M, Hiraki T, Sugimoto T, Akahane T, Yonezawa S, Kornmann M, Batra SK, Hollingsworth MA, Tanimoto A. Predicted Prognosis of Pancreatic Cancer Patients by Machine Learning. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31992588 DOI: 10.1158/1078-0432.Ccr-19-1247  0.44
2019 Shakri AR, Zhong TJ, Ma W, Coker C, Kim S, Calluori S, Scholze H, Szabolcs M, Caffrey T, Grandgenett PM, Hollingsworth MA, Tanji K, Kluger MD, Miller G, Biswas AK, et al. Upregulation of ZIP14 and Altered Zinc Homeostasis in Muscles in Pancreatic Cancer Cachexia. Cancers. 12. PMID 31861290 DOI: 10.3390/Cancers12010003  0.44
2019 Law HC, Lagundžin D, Clement EJ, Qiao F, Wagner ZS, Krieger KL, Costanzo-Garvey D, Caffrey TC, Grem JL, DiMaio DJ, Grandgenett PM, Cook LM, Fisher KW, Yu F, Hollingsworth MA, et al. The Proteomic Landscape of Pancreatic Ductal Adenocarcinoma Liver Metastases Identifies Molecular Subtypes and Associations with Clinical Response. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31848187 DOI: 10.1158/1078-0432.CCR-19-1496  0.64
2019 Liu X, Clemens DL, Grunkemeyer JA, Price JD, O'Connell K, Chapman NM, Storz P, Wen H, Cox JL, Reid WL, Hollingsworth MA, Thayer S. Mucin-1 is required for Coxsackie Virus B3-induced inflammation in pancreatitis. Scientific Reports. 9: 10656. PMID 31337812 DOI: 10.1038/s41598-019-46933-y  0.44
2019 Caffrey T, Sagar S, Thomas D, Lewallen ME, Hollingsworth MA, Radhakrishnan P. The Glycoprotein Mucin-1 Negatively Regulates GalNAc Transferase 5 Expression in Pancreatic Cancer. Febs Letters. PMID 31283009 DOI: 10.1002/1873-3468.13532  0.4
2019 Shi Y, Gao W, Lytle NK, Huang P, Yuan X, Dann AM, Ridinger-Saison M, DelGiorno KE, Antal CE, Liang G, Atkins AR, Erikson G, Sun H, Meisenhelder J, Terenziani E, ... ... Hollingsworth MA, et al. Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring. Nature. PMID 30996350 DOI: 10.1038/S41586-019-1130-6  0.44
2019 Haney SL, Varney ML, Chhonker YS, Shin S, Mehla K, Crawford AJ, Smith HJ, Smith LM, Murry DJ, Hollingsworth MA, Holstein SA. Inhibition of geranylgeranyl diphosphate synthase is a novel therapeutic strategy for pancreatic ductal adenocarcinoma. Oncogene. PMID 30918331 DOI: 10.1038/s41388-019-0794-6  0.76
2019 Soni KS, Thomas D, Caffrey T, Mehla K, Lei F, O'Connell KA, Sagar S, Lele SM, Hollingsworth MA, Radhakrishnan P, Bronich TK. Polymeric Nanogel-based Treatment Regimen for Enhanced Efficacy and Sequential Administration of Synergistic Drug Combination in Pancreatic Cancer. The Journal of Pharmacology and Experimental Therapeutics. PMID 30683666 DOI: 10.1124/jpet.118.255372  0.76
2018 Torphy RJ, Wang Z, True-Yasaki A, Volmar KE, Rashid N, Yeh B, Anderson JM, Johansen JS, Hollingsworth MA, Yeh JJ, Collisson EA. Stromal Content Is Correlated With Tissue Site, Contrast Retention, and Survival in Pancreatic Adenocarcinoma. Jco Precision Oncology. 2018. PMID 30506016  0.44
2018 Wang G, Biswas AK, Ma W, Kandpal M, Coker C, Grandgenett PM, Hollingsworth MA, Jain R, Tanji K, Lόpez-Pintado S, Borczuk A, Hebert D, Jenkitkasemwong S, Hojyo S, Davuluri RV, et al. Metastatic cancers promote cachexia through ZIP14 upregulation in skeletal muscle. Nature Medicine. 24: 770-781. PMID 29875463 DOI: 10.1038/s41591-018-0054-2  0.44
2018 Tiriac H, Belleau P, Engle DD, Plenker D, Deschênes A, Somerville T, Froeling FEM, Burkhart RA, Denroche RE, Jang GH, Miyabayashi K, Young CM, Patel H, Ma M, LaComb JF, ... ... Hollingsworth MA, et al. Organoid profiling identifies common responders to chemotherapy in pancreatic cancer. Cancer Discovery. PMID 29853643 DOI: 10.1158/2159-8290.Cd-18-0349  0.44
2017 Mehla K, Tremayne J, Grunkemeyer JA, O'Connell KA, Steele MM, Caffrey TC, Zhu X, Yu F, Singh PK, Schultes BC, Madiyalakan R, Nicodemus CF, Hollingsworth MA. Combination of mAb-AR20.5, anti-PD-L1 and PolyICLC inhibits tumor progression and prolongs survival of MUC1.Tg mice challenged with pancreatic tumors. Cancer Immunology, Immunotherapy : Cii. PMID 29204701 DOI: 10.1007/s00262-017-2095-7  0.84
2017 Shukla SK, Purohit V, Mehla K, Gunda V, Chaika NV, Vernucci E, King RJ, Abrego J, Goode GD, Dasgupta A, Illies AL, Gebregiworgis T, Dai B, Augustine JJ, Murthy D, ... ... Hollingsworth MA, et al. MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer. Cancer Cell. 32: 392. PMID 28898700 DOI: 10.1016/J.Ccell.2017.08.008  0.84
2017 Roe JS, Hwang CI, Somerville TDD, Milazzo JP, Lee EJ, Da Silva B, Maiorino L, Tiriac H, Young CM, Miyabayashi K, Filippini D, Creighton B, Burkhart RA, Buscaglia JM, Kim EJ, ... ... Hollingsworth MA, et al. Enhancer Reprogramming Promotes Pancreatic Cancer Metastasis. Cell. PMID 28757253 DOI: 10.1016/J.Cell.2017.07.007  0.44
2017 Shukla SK, Purohit V, Mehla K, Gunda V, Chaika NV, Vernucci E, King RJ, Abrego J, Goode GD, Dasgupta A, Illies AL, Gebregiworgis T, Dai B, Augustine JJ, Murthy D, ... ... Hollingsworth MA, et al. MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer. Cancer Cell. 32: 71-87.e7. PMID 28697344 DOI: 10.1016/J.Ccell.2017.06.004  0.84
2017 Yokoyama S, Higashi M, Tsutsumida H, Wakimoto J, Hamada T, Wiest E, Matsuo K, Kitazono I, Goto Y, Guo X, Hamada T, Yamada S, Hiraki T, Yonezawa S, Batra SK, ... Hollingsworth MA, et al. TET1-mediated DNA hypomethylation regulates the expression of MUC4 in lung cancer. Genes & Cancer. 8: 517-527. PMID 28680536 DOI: 10.18632/Genesandcancer.139  0.44
2016 Clausen TM, Pereira MA, Al Nakouzi N, Oo HZ, Agerbæk MO, Lee S, Orum-Madsen MS, Kristensen AR, El-Naggar A, Grandgenett PM, Grem JL, Hollingsworth MA, Holst PJ, Theander TG, Sorensen PH, et al. Oncofetal Chondroitin Sulfate Glycosaminoglycans are Key Players in Integrin Signaling and Tumor Cell Motility. Molecular Cancer Research : McR. PMID 27655130 DOI: 10.1158/1541-7786.MCR-16-0103  0.44
2016 Sousa AM, Rei M, Freitas R, Ricardo S, Caffrey T, David L, Almeida R, Hollingsworth MA, Santos-Silva F. Effect of MUC1/β-catenin interaction on the tumorigenic capacity of pancreatic CD133(+) cells. Oncology Letters. 12: 1811-1817. PMID 27602113 DOI: 10.3892/ol.2016.4888  1
2016 Sousa AM, Grandgenett PM, David L, Almeida R, Hollingsworth MA, Santos-Silva F. Reflections on MUC1 glycoprotein: the hidden potential of isoforms in carcinogenesis. Apmis : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. PMID 27538373 DOI: 10.1111/apm.12587  0.44
2016 Yokoyama S, Higashi M, Kitamoto S, Oeldorf M, Knippschild U, Kornmann M, Maemura K, Kurahara H, Wiest E, Hamada T, Kitazono I, Goto Y, Tasaki T, Hiraki T, Hatanaka K, ... ... Hollingsworth MA, et al. Aberrant methylation of MUC1 and MUC4 promoters are potential prognostic biomarkers for pancreatic ductal adenocarcinomas. Oncotarget. PMID 27283771 DOI: 10.18632/Oncotarget.9924  0.44
2016 Fox RG, Lytle NK, Jaquish DV, Park FD, Ito T, Bajaj J, Koechlein CS, Zimdahl B, Yano M, Kopp JL, Kritzik M, Sicklick JK, Sander M, Grandgenett PM, Hollingsworth MA, et al. Image-based detection and targeting of therapy resistance in pancreatic adenocarcinoma. Nature. PMID 27281208 DOI: 10.1038/Nature17988  0.44
2016 Hanson RL, Brown RB, Steele MM, Grandgenett PM, Grunkemeyer JA, Hollingsworth MA. Identification of FRA-1 as a novel player in pancreatic cancer in cooperation with a MUC1: ERK signaling axis. Oncotarget. PMID 27220889 DOI: 10.18632/oncotarget.9557  1
2016 Wuebben EL, Wilder PJ, Cox JL, Grunkemeyer JA, Caffrey T, Hollingsworth MA, Rizzino A. SOX2 functions as a molecular rheostat to control the growth, tumorigenicity and drug responses of pancreatic ductal adenocarcinoma cells. Oncotarget. PMID 27145457 DOI: 10.18632/Oncotarget.8994  1
2016 Katchman BA, Barderas R, Alam R, Chowell D, Field MS, Esserman LJ, Wallstrom G, LaBaer J, Cramer D, Hollingsworth MA, Anderson KS. Proteomic Mapping of p53 Immunogenicity in Pancreatic, Ovarian, and Breast Cancers. Proteomics. Clinical Applications. PMID 27121307 DOI: 10.1002/prca.201500096  1
2016 Krishn SR, Kaur S, Smith LM, Johansson SL, Jain M, Patel A, Gautam SK, Hollingsworth MA, Mandel U, Clausen H, Lo WC, Fan WL, Manne U, Batra SK. Mucins and associated glycan signatures in colon adenoma-carcinoma sequence: Prospective pathological implication(s) for early diagnosis of colon cancer. Cancer Letters. PMID 26898938 DOI: 10.1016/J.Canlet.2016.02.016  1
2015 Fink DM, Steele MM, Hollingsworth MA. The lymphatic system and pancreatic cancer. Cancer Letters. PMID 26742462 DOI: 10.1016/j.canlet.2015.11.048  1
2015 Hoshino A, Costa-Silva B, Shen TL, Rodrigues G, Hashimoto A, Tesic Mark M, Molina H, Kohsaka S, Di Giannatale A, Ceder S, Singh S, Williams C, Soplop N, Uryu K, Pharmer L, ... ... Hollingsworth MA, et al. Tumour exosome integrins determine organotropic metastasis. Nature. PMID 26524530 DOI: 10.1038/Nature15756  1
2015 Haab BB, Huang Y, Balasenthil S, Partyka K, Tang H, Anderson M, Allen P, Sasson A, Zeh H, Kaul K, Kletter D, Ge S, Bern M, Kwon R, Blasutig I, ... ... Hollingsworth MA, et al. Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specimens. Plos One. 10: e0139049. PMID 26431551 DOI: 10.1371/Journal.Pone.0139049  1
2015 Moffitt RA, Marayati R, Flate EL, Volmar KE, Loeza SG, Hoadley KA, Rashid NU, Williams LA, Eaton SC, Chung AH, Smyla JK, Anderson JM, Kim HJ, Bentrem DJ, Talamonti MS, ... ... Hollingsworth MA, et al. Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma. Nature Genetics. 47: 1168-78. PMID 26343385 DOI: 10.1038/Ng.3398  1
2015 Costa-Silva B, Aiello NM, Ocean AJ, Singh S, Zhang H, Thakur BK, Becker A, Hoshino A, Mark MT, Molina H, Xiang J, Zhang T, Theilen TM, García-Santos G, Williams C, ... ... Hollingsworth MA, et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nature Cell Biology. 17: 816-26. PMID 25985394 DOI: 10.1038/Ncb3169  1
2015 Chari ST, Kelly K, Hollingsworth MA, Thayer SP, Ahlquist DA, Andersen DK, Batra SK, Brentnall TA, Canto M, Cleeter DF, Firpo MA, Gambhir SS, Go VL, Hines OJ, Kenner BJ, et al. Early Detection of Sporadic Pancreatic Cancer: Summative Review. Pancreas. 44: 693-712. PMID 25931254 DOI: 10.1097/Mpa.0000000000000368  1
2015 Londin E, Loher P, Telonis AG, Quann K, Clark P, Jing Y, Hatzimichael E, Kirino Y, Honda S, Lally M, Ramratnam B, Comstock CE, Knudsen KE, Gomella L, Spaeth GL, ... ... Hollingsworth MA, et al. Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAs. Proceedings of the National Academy of Sciences of the United States of America. 112: E1106-15. PMID 25713380 DOI: 10.1073/Pnas.1420955112  1
2015 Pandey P, Rachagani S, Das S, Seshacharyulu P, Sheinin Y, Naslavsky N, Pan Z, Smith BL, Peters HL, Radhakrishnan P, McKenna NR, Giridharan SS, Haridas D, Kaur S, Hollingsworth MA, et al. Amyloid precursor-like protein 2 (APLP2) affects the actin cytoskeleton and increases pancreatic cancer growth and metastasis. Oncotarget. 6: 2064-75. PMID 25576918 DOI: 10.18632/Oncotarget.2990  1
2015 Kelly KA, Hollingsworth MA, Brand RE, Liu CH, Singh VK, Srivastava S, Wasan AD, Yadav D, Andersen DK. Advances in biomedical imaging, bioengineering, and related technologies for the development of biomarkers of pancreatic disease summary of a national institute of diabetes and digestive and kidney diseases and national institute of biomedical imaging and bioengineering workshop Pancreas. 44: 1185-1194.  1
2014 Liu X, Huang H, Remmers N, Hollingsworth MA. Loss of E-cadherin and epithelial to mesenchymal transition is not required for cell motility in tissues or for metastasis. Tissue Barriers. 2: e969112. PMID 25610757 DOI: 10.4161/21688362.2014.969112  0.44
2014 Fink DM, Connor AL, Kelley PM, Steele MM, Hollingsworth MA, Tempero RM. Nerve growth factor regulates neurolymphatic remodeling during corneal inflammation and resolution. Plos One. 9: e112737. PMID 25383879 DOI: 10.1371/journal.pone.0112737  1
2014 Zhao Q, Piyush T, Chen C, Hollingsworth MA, Hilkens J, Rhodes JM, Yu LG. MUC1 extracellular domain confers resistance of epithelial cancer cells to anoikis. Cell Death & Disease. 5: e1438. PMID 25275599 DOI: 10.1038/cddis.2014.421  1
2014 Mirus JE, Zhang Y, Hollingsworth MA, Solan JL, Lampe PD, Hingorani SR. Spatiotemporal proteomic analyses during pancreas cancer progression identifies serine/threonine stress kinase 4 (STK4) as a novel candidate biomarker for early stage disease. Molecular & Cellular Proteomics : McP. 13: 3484-96. PMID 25225358 DOI: 10.1074/Mcp.M113.036517  1
2014 Radhakrishnan P, Dabelsteen S, Madsen FB, Francavilla C, Kopp KL, Steentoft C, Vakhrushev SY, Olsen JV, Hansen L, Bennett EP, Woetmann A, Yin G, Chen L, Song H, Bak M, ... ... Hollingsworth MA, et al. Immature truncated O-glycophenotype of cancer directly induces oncogenic features. Proceedings of the National Academy of Sciences of the United States of America. 111: E4066-75. PMID 25118277 DOI: 10.1073/pnas.1406619111  1
2014 Liu X, Caffrey TC, Steele MM, Mohr A, Singh PK, Radhakrishnan P, Kelly DL, Wen Y, Hollingsworth MA. MUC1 regulates cyclin D1 gene expression through p120 catenin and β-catenin. Oncogenesis. 3: e107. PMID 24979278 DOI: 10.1038/oncsis.2014.19  1
2014 Cox JL, Wilder PJ, Wuebben EL, Ouellette MM, Hollingsworth MA, Rizzino A. Context-dependent function of the deubiquitinating enzyme USP9X in pancreatic ductal adenocarcinoma. Cancer Biology & Therapy. 15: 1042-52. PMID 24841553 DOI: 10.4161/Cbt.29182  1
2014 Thege FI, Lannin TB, Saha TN, Tsai S, Kochman ML, Hollingsworth MA, Rhim AD, Kirby BJ. Microfluidic immunocapture of circulating pancreatic cells using parallel EpCAM and MUC1 capture: characterization, optimization and downstream analysis. Lab On a Chip. 14: 1775-84. PMID 24681997 DOI: 10.1039/c4lc00041b  1
2014 Liu X, Yi C, Wen Y, Radhakrishnan P, Tremayne JR, Dao T, Johnson KR, Hollingsworth MA. Interactions between MUC1 and p120 catenin regulate dynamic features of cell adhesion, motility, and metastasis. Cancer Research. 74: 1609-20. PMID 24371222 DOI: 10.1158/0008-5472.CAN-13-2444  1
2014 Kaur S, Sharma N, Krishn SR, Lakshmanan I, Rachagani S, Baine MJ, Smith LM, Lele SM, Sasson AR, Guha S, Mallya K, Anderson JM, Hollingsworth MA, Batra SK. MUC4-mediated regulation of acute phase protein lipocalin 2 through HER2/AKT/NF-κB signaling in pancreatic cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 688-700. PMID 24240113 DOI: 10.1158/1078-0432.Ccr-13-2174  1
2013 Radhakrishnan P, Mohr AM, Grandgenett PM, Steele MM, Batra SK, Hollingsworth MA. MicroRNA-200c modulates the expression of MUC4 and MUC16 by directly targeting their coding sequences in human pancreatic cancer. Plos One. 8: e73356. PMID 24204560 DOI: 10.1371/Journal.Pone.0073356  1
2013 Mohr AM, Bailey JM, Lewallen ME, Liu X, Radhakrishnan P, Yu F, Tapprich W, Hollingsworth MA. MUC1 regulates expression of multiple microRNAs involved in pancreatic tumor progression, including the miR-200c/141 cluster. Plos One. 8: e73306. PMID 24143167 DOI: 10.1371/journal.pone.0073306  1
2013 Radhakrishnan P, Grandgenett PM, Mohr AM, Bunt SK, Yu F, Chowdhury S, Hollingsworth MA. Expression of core 3 synthase in human pancreatic cancer cells suppresses tumor growth and metastasis. International Journal of Cancer. Journal International Du Cancer. 133: 2824-33. PMID 23754791 DOI: 10.1002/ijc.28322  1
2013 Burford B, Gentry-Maharaj A, Graham R, Allen D, Pedersen JW, Nudelman AS, Blixt O, Fourkala EO, Bueti D, Dawnay A, Ford J, Desai R, David L, Trinder P, Acres B, ... ... Hollingsworth MA, et al. Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer. British Journal of Cancer. 108: 2045-55. PMID 23652307 DOI: 10.1038/bjc.2013.214  1
2013 Lin WC, Rajbhandari N, Liu C, Sakamoto K, Zhang Q, Triplett AA, Batra SK, Opavsky R, Felsher DW, DiMaio DJ, Hollingsworth MA, Morris JP, Hebrok M, Witkiewicz AK, Brody JR, et al. Dormant cancer cells contribute to residual disease in a model of reversible pancreatic cancer. Cancer Research. 73: 1821-30. PMID 23467612 DOI: 10.1158/0008-5472.Can-12-2067  1
2013 Remmers N, Anderson JM, Linde EM, DiMaio DJ, Lazenby AJ, Wandall HH, Mandel U, Clausen H, Yu F, Hollingsworth MA. Aberrant expression of mucin core proteins and o-linked glycans associated with progression of pancreatic cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 1981-93. PMID 23446997 DOI: 10.1158/1078-0432.CCR-12-2662  1
2013 Radhakrishnan P, Bryant VC, Blowers EC, Rajule RN, Gautam N, Anwar MM, Mohr AM, Grandgenett PM, Bunt SK, Arnst JL, Lele SM, Alnouti Y, Hollingsworth MA, Natarajan A. Targeting the NF-κB and mTOR pathways with a quinoxaline urea analog that inhibits IKKβ for pancreas cancer therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 2025-35. PMID 23444213 DOI: 10.1158/1078-0432.CCR-12-2909  1
2013 Bunt SK, Mohr AM, Bailey JM, Grandgenett PM, Hollingsworth MA. Rosiglitazone and Gemcitabine in combination reduces immune suppression and modulates T cell populations in pancreatic cancer. Cancer Immunology, Immunotherapy : Cii. 62: 225-36. PMID 22864396 DOI: 10.1007/s00262-012-1324-3  1
2013 Hollingsworth MA. Translational implications of molecular genetics for early diagnosis of pancreatic cancer Molecular Genetics of Pancreatic Cancer. 2147483647: 75-82. DOI: 10.1007/978-1-4614-6549-2_4  1
2012 Dey P, Rachagani S, Chakraborty S, Singh PK, Zhao X, Gurumurthy CB, Anderson JM, Lele S, Hollingsworth MA, Band V, Batra SK. Overexpression of ecdysoneless in pancreatic cancer and its role in oncogenesis by regulating glycolysis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 6188-98. PMID 22977192 DOI: 10.1158/1078-0432.Ccr-12-1789  1
2012 Chaika NV, Gebregiworgis T, Lewallen ME, Purohit V, Radhakrishnan P, Liu X, Zhang B, Mehla K, Brown RB, Caffrey T, Yu F, Johnson KR, Powers R, Hollingsworth MA, Singh PK. MUC1 mucin stabilizes and activates hypoxia-inducible factor 1 alpha to regulate metabolism in pancreatic cancer. Proceedings of the National Academy of Sciences of the United States of America. 109: 13787-92. PMID 22869720 DOI: 10.1073/pnas.1203339109  1
2012 Peters HL, Tuli A, Wang X, Liu C, Pan Z, Ouellette MM, Hollingsworth MA, Macdonald RG, Solheim JC. Relevance of amyloid precursor-like protein 2 C-terminal fragments in pancreatic cancer cells. International Journal of Oncology. 41: 1464-74. PMID 22797723 DOI: 10.3892/ijo.2012.1553  1
2012 Mutolo MJ, Morris KJ, Leir SH, Caffrey TC, Lewandowska MA, Hollingsworth MA, Harris A. Tumor suppression by collagen XV is independent of the restin domain. Matrix Biology : Journal of the International Society For Matrix Biology. 31: 285-9. PMID 22531369 DOI: 10.1016/j.matbio.2012.03.003  1
2012 Chaika NV, Yu F, Purohit V, Mehla K, Lazenby AJ, DiMaio D, Anderson JM, Yeh JJ, Johnson KR, Hollingsworth MA, Singh PK. Differential expression of metabolic genes in tumor and stromal components of primary and metastatic loci in pancreatic adenocarcinoma. Plos One. 7: e32996. PMID 22412968 DOI: 10.1371/journal.pone.0032996  1
2012 Remmers N, Bailey JM, Mohr AM, Hollingsworth MA. MOlecular Pathology Of Early Pancreatic Cancer Translational Pathology of Early Cancer. 421-440. DOI: 10.3233/978-1-61499-024-6-421  1
2011 Singh PK, Mehla K, Hollingsworth MA, Johnson KR. Regulation of Aerobic Glycolysis by microRNAs in Cancer. Molecular and Cellular Pharmacology. 3: 125-134. PMID 22792411 DOI: 10.4255/mcpharmacol.11.17  1
2011 Costa NR, Paulo P, Caffrey T, Hollingsworth MA, Santos-Silva F. Impact of MUC1 mucin downregulation in the phenotypic characteristics of MKN45 gastric carcinoma cell line. Plos One. 6: e26970. PMID 22073229 DOI: 10.1371/journal.pone.0026970  1
2011 Haridas D, Chakraborty S, Ponnusamy MP, Lakshmanan I, Rachagani S, Cruz E, Kumar S, Das S, Lele SM, Anderson JM, Wittel UA, Hollingsworth MA, Batra SK. Pathobiological implications of MUC16 expression in pancreatic cancer. Plos One. 6: e26839. PMID 22066010 DOI: 10.1371/Journal.Pone.0026839  1
2011 Eggers JP, Grandgenett PM, Collisson EC, Lewallen ME, Tremayne J, Singh PK, Swanson BJ, Andersen JM, Caffrey TC, High RR, Ouellette M, Hollingsworth MA. Cyclin-dependent kinase 5 is amplified and overexpressed in pancreatic cancer and activated by mutant K-Ras. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 6140-50. PMID 21825040 DOI: 10.1158/1078-0432.CCR-10-2288  1
2011 Ruiz C, Lenkiewicz E, Evers L, Holley T, Robeson A, Kiefer J, Demeure MJ, Hollingsworth MA, Shen M, Prunkard D, Rabinovitch PS, Zellweger T, Mousses S, Trent JM, Carpten JD, et al. Advancing a clinically relevant perspective of the clonal nature of cancer. Proceedings of the National Academy of Sciences of the United States of America. 108: 12054-9. PMID 21730190 DOI: 10.1073/pnas.1104009108  1
2011 Taniuchi K, Nishimori I, Hollingsworth MA. The N-terminal domain of G3BP enhances cell motility and invasion by posttranscriptional regulation of BART. Molecular Cancer Research : McR. 9: 856-66. PMID 21665939 DOI: 10.1158/1541-7786.MCR-10-0574  1
2011 Taniuchi K, Cerny RL, Tanouchi A, Kohno K, Kotani N, Honke K, Saibara T, Hollingsworth MA. Overexpression of GalNAc-transferase GalNAc-T3 promotes pancreatic cancer cell growth. Oncogene. 30: 4843-54. PMID 21625220 DOI: 10.1038/onc.2011.194  1
2011 Taniuchi K, Nishimori I, Hollingsworth MA. Intracellular CD24 inhibits cell invasion by posttranscriptional regulation of BART through interaction with G3BP. Cancer Research. 71: 895-905. PMID 21266361 DOI: 10.1158/0008-5472.CAN-10-2743  1
2010 Remmers N, Bailey JM, Mohr AM, Hollingsworth MA. Molecular pathology of early pancreatic cancer. Cancer Biomarkers : Section a of Disease Markers. 9: 421-40. PMID 22112488 DOI: 10.3233/CBM-2011-0168  1
2010 Behrens ME, Grandgenett PM, Bailey JM, Singh PK, Yi CH, Yu F, Hollingsworth MA. The reactive tumor microenvironment: MUC1 signaling directly reprograms transcription of CTGF. Oncogene. 29: 5667-77. PMID 20697347 DOI: 10.1038/onc.2010.327  1
2010 Stratford JK, Bentrem DJ, Anderson JM, Fan C, Volmar KA, Marron JS, Routh ED, Caskey LS, Samuel JC, Der CJ, Thorne LB, Calvo BF, Kim HJ, Talamonti MS, Iacobuzio-Donahue CA, ... Hollingsworth MA, et al. A six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinoma. Plos Medicine. 7: e1000307. PMID 20644708 DOI: 10.1371/Journal.Pmed.1000307  1
2010 Wandall HH, Blixt O, Tarp MA, Pedersen JW, Bennett EP, Mandel U, Ragupathi G, Livingston PO, Hollingsworth MA, Taylor-Papadimitriou J, Burchell J, Clausen H. Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes. Cancer Research. 70: 1306-13. PMID 20124478 DOI: 10.1158/0008-5472.CAN-09-2893  1
2009 Bailey JM, Creamer BA, Hollingsworth MA. What a fish can learn from a mouse: principles and strategies for modeling human cancer in mice. Zebrafish. 6: 329-37. PMID 20047466 DOI: 10.1089/zeb.2009.0626  1
2009 Moniaux N, Nemos C, Deb S, Zhu B, Dornreiter I, Hollingsworth MA, Batra SK. The human RNA polymerase II-associated factor 1 (hPaf1): a new regulator of cell-cycle progression. Plos One. 4: e7077. PMID 19771162 DOI: 10.1371/Journal.Pone.0007077  1
2009 Bailey JM, Mohr AM, Hollingsworth MA. Sonic hedgehog paracrine signaling regulates metastasis and lymphangiogenesis in pancreatic cancer. Oncogene. 28: 3513-25. PMID 19633682 DOI: 10.1038/onc.2009.220  1
2009 Yue T, Goldstein IJ, Hollingsworth MA, Kaul K, Brand RE, Haab BB. The prevalence and nature of glycan alterations on specific proteins in pancreatic cancer patients revealed using antibody-lectin sandwich arrays. Molecular & Cellular Proteomics : McP. 8: 1697-707. PMID 19377061 DOI: 10.1074/Mcp.M900135-Mcp200  1
2009 Wilder PJ, Chakravarthy H, Hollingsworth MA, Rizzino A. Comparison of ras-responsive gene enhancers in pancreatic tumor cells that express either wild-type or mutant K-ras. Biochemical and Biophysical Research Communications. 381: 706-11. PMID 19254697 DOI: 10.1016/j.bbrc.2009.02.126  1
2008 Bailey JM, Swanson BJ, Hamada T, Eggers JP, Singh PK, Caffery T, Ouellette MM, Hollingsworth MA. Sonic hedgehog promotes desmoplasia in pancreatic cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 5995-6004. PMID 18829478 DOI: 10.1158/1078-0432.CCR-08-0291  1
2008 Singh PK, Behrens ME, Eggers JP, Cerny RL, Bailey JM, Shanmugam K, Gendler SJ, Bennett EP, Hollingsworth MA. Phosphorylation of MUC1 by Met modulates interaction with p53 and MMP1 expression. The Journal of Biological Chemistry. 283: 26985-95. PMID 18625714 DOI: 10.1074/jbc.M805036200  1
2008 Moniaux N, Chakraborty S, Yalniz M, Gonzalez J, Shostrom VK, Standop J, Lele SM, Ouellette M, Pour PM, Sasson AR, Brand RE, Hollingsworth MA, Jain M, Batra SK. Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia. British Journal of Cancer. 98: 1540-7. PMID 18392050 DOI: 10.1038/Sj.Bjc.6604329  1
2008 Chaturvedi P, Singh AP, Chakraborty S, Chauhan SC, Bafna S, Meza JL, Singh PK, Hollingsworth MA, Mehta PP, Batra SK. MUC4 mucin interacts with and stabilizes the HER2 oncoprotein in human pancreatic cancer cells. Cancer Research. 68: 2065-70. PMID 18381409 DOI: 10.1158/0008-5472.Can-07-6041  1
2008 Costa NR, Mendes N, Marcos NT, Reis CA, Caffrey T, Hollingsworth MA, Santos-Silva F. Relevance of MUC1 mucin variable number of tandem repeats polymorphism in H pylori adhesion to gastric epithelial cells. World Journal of Gastroenterology. 14: 1411-4. PMID 18322957 DOI: 10.3748/wjg.14.1411  1
2008 Shintani Y, Fukumoto Y, Chaika N, Grandgenett PM, Hollingsworth MA, Wheelock MJ, Johnson KR. ADH-1 suppresses N-cadherin-dependent pancreatic cancer progression. International Journal of Cancer. Journal International Du Cancer. 122: 71-7. PMID 17721921 DOI: 10.1002/ijc.23027  1
2008 Chaturvedi P, Singh AP, Chakraborty S, Chauhan SC, Bafna S, Meza JL, Singh PK, Hollingsworth MA, Mehta PP, Batra SK. MUC4 mucin interacts with and stabilizes the HER2 oncoprotein in human pancreatic cancer cells (Cancer Research (April 1, 2008) 68(2065-2070)) Cancer Research. 68: 3549. DOI: 10.1158/0008-5472.Can-68-9-Cor3  1
2008 Swanson BJ, McDermott KM, Singh PK, Eggers JP, Crocker PR, Hollingsworth MA. MUC1 is a counter-receptor for myelin-associated glycoprotein (Siglec-4a) and their interaction contributes to adhesion in pancreatic cancer perineural invasion (Cancer Research (2007) 67, (10222-10229)) Cancer Research. 68: 338. DOI: 10.1158/0008-5472.CAN-68-1-COR  1
2008 Hassan H, Bennett EP, Mandel U, Hollingsworth MA, Clausen H. Control of mucin-type o-glycosylation: O-glycan occupancy is directed by substrate specificities of polypeptide GalNAc-transferases Carbohydrates in Chemistry and Biology. 3: 273-292. DOI: 10.1002/9783527618255.ch55  1
2007 Harris A, Harris H, Hollingsworth MA. Complete suppression of tumor formation by high levels of basement membrane collagen. Molecular Cancer Research : McR. 5: 1241-5. PMID 18171981 DOI: 10.1158/1541-7786.MCR-07-0200  1
2007 Swanson BJ, McDermott KM, Singh PK, Eggers JP, Crocker PR, Hollingsworth MA. MUC1 is a counter-receptor for myelin-associated glycoprotein (Siglec-4a) and their interaction contributes to adhesion in pancreatic cancer perineural invasion. Cancer Research. 67: 10222-9. PMID 17974963 DOI: 10.1158/0008-5472.CAN-06-2483  1
2007 Bailey JM, Singh PK, Hollingsworth MA. Cancer metastasis facilitated by developmental pathways: Sonic hedgehog, Notch, and bone morphogenic proteins. Journal of Cellular Biochemistry. 102: 829-39. PMID 17914743 DOI: 10.1002/jcb.21509  1
2007 Ashour AE, Turnquist HR, Burns N, Wang X, Lin X, Tremayne J, Hollingsworth MA, Blonder JM, Rosenthal GJ, Talmadge JE, Solheim JC. Flt3 ligand delivered in a pluronic formulation prolongs the survival of mice with orthotopic pancreatic adenocarcinoma. Cancer Biotherapy & Radiopharmaceuticals. 22: 235-8. PMID 17600470 DOI: 10.1089/cbr.2007.336  1
2007 Yi CH, Smith DJ, West WW, Hollingsworth MA. Loss of fibulin-2 expression is associated with breast cancer progression. The American Journal of Pathology. 170: 1535-45. PMID 17456760 DOI: 10.2353/ajpath.2007.060478  1
2007 Tsutsumida H, Nomoto M, Goto M, Kitajima S, Kubota I, Hirotsu Y, Wakimoto J, Hollingsworth MA, Yonezawa S. A micropapillary pattern is predictive of a poor prognosis in lung adenocarcinoma, and reduced surfactant apoprotein A expression in the micropapillary pattern is an excellent indicator of a poor prognosis. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 20: 638-47. PMID 17431413 DOI: 10.1038/modpathol.3800780  1
2007 Turnquist HR, Lin X, Ashour AE, Hollingsworth MA, Singh RK, Talmadge JE, Solheim JC. CCL21 induces extensive intratumoral immune cell infiltration and specific anti-tumor cellular immunity. International Journal of Oncology. 30: 631-9. PMID 17273764  1
2007 Wandall HH, Irazoqui F, Tarp MA, Bennett EP, Mandel U, Takeuchi H, Kato K, Irimura T, Suryanarayanan G, Hollingsworth MA, Clausen H. The lectin domains of polypeptide GalNAc-transferases exhibit carbohydrate-binding specificity for GalNAc: lectin binding to GalNAc-glycopeptide substrates is required for high density GalNAc-O-glycosylation. Glycobiology. 17: 374-87. PMID 17215257 DOI: 10.1093/glycob/cwl082  1
2007 Singh AP, Chauhan SC, Andrianifahanana M, Moniaux N, Meza JL, Copin MC, van Seuningen I, Hollingsworth MA, Aubert JP, Batra SK. MUC4 expression is regulated by cystic fibrosis transmembrane conductance regulator in pancreatic adenocarcinoma cells via transcriptional and post-translational mechanisms. Oncogene. 26: 30-41. PMID 16799633 DOI: 10.1038/Sj.Onc.1209764  1
2006 Shintani Y, Hollingsworth MA, Wheelock MJ, Johnson KR. Collagen I promotes metastasis in pancreatic cancer by activating c-Jun NH(2)-terminal kinase 1 and up-regulating N-cadherin expression. Cancer Research. 66: 11745-53. PMID 17178870 DOI: 10.1158/0008-5472.CAN-06-2322  1
2006 Singh PK, Hollingsworth MA. Cell surface-associated mucins in signal transduction. Trends in Cell Biology. 16: 467-76. PMID 16904320 DOI: 10.1016/j.tcb.2006.07.006  1
2006 Tsutsumida H, Swanson BJ, Singh PK, Caffrey TC, Kitajima S, Goto M, Yonezawa S, Hollingsworth MA. RNA interference suppression of MUC1 reduces the growth rate and metastatic phenotype of human pancreatic cancer cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 2976-87. PMID 16707592 DOI: 10.1158/1078-0432.CCR-05-1197  1
2006 Moniaux N, Nemos C, Schmied BM, Chauhan SC, Deb S, Morikane K, Choudhury A, Vanlith M, Sutherlin M, Sikela JM, Hollingsworth MA, Batra SK. The human homologue of the RNA polymerase II-associated factor 1 (hPaf1), localized on the 19q13 amplicon, is associated with tumorigenesis. Oncogene. 25: 3247-57. PMID 16491129 DOI: 10.1038/Sj.Onc.1209353  1
2006 Sørensen AL, Reis CA, Tarp MA, Mandel U, Ramachandran K, Sankaranarayanan V, Schwientek T, Graham R, Taylor-Papadimitriou J, Hollingsworth MA, Burchell J, Clausen H. Chemoenzymatically synthesized multimeric Tn/STn MUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override tolerance. Glycobiology. 16: 96-107. PMID 16207894 DOI: 10.1093/glycob/cwj044  1
2005 Acharyya S, Butchbach ME, Sahenk Z, Wang H, Saji M, Carathers M, Ringel MD, Skipworth RJ, Fearon KC, Hollingsworth MA, Muscarella P, Burghes AH, Rafael-Fortney JA, Guttridge DC. Dystrophin glycoprotein complex dysfunction: a regulatory link between muscular dystrophy and cancer cachexia. Cancer Cell. 8: 421-32. PMID 16286249 DOI: 10.1016/j.ccr.2005.10.004  1
2005 Palmai-Pallag T, Khodabukus N, Kinarsky L, Leir SH, Sherman S, Hollingsworth MA, Harris A. The role of the SEA (sea urchin sperm protein, enterokinase and agrin) module in cleavage of membrane-tethered mucins. The Febs Journal. 272: 2901-11. PMID 15943821 DOI: 10.1111/j.1742-4658.2005.04711.x  1
2005 Lee KM, Yasuda H, Hollingsworth MA, Ouellette MM. Notch 2-positive progenitors with the intrinsic ability to give rise to pancreatic ductal cells. Laboratory Investigation; a Journal of Technical Methods and Pathology. 85: 1003-12. PMID 15924149 DOI: 10.1038/labinvest.3700298  1
2005 Shiraga T, Winpenny JP, Carter EJ, McCarthy VA, Hollingsworth MA, Harris A. MZF-1 and DbpA interact with DNase I hypersensitive sites that correlate with expression of the human MUC1 mucin gene. Experimental Cell Research. 308: 41-52. PMID 15893750 DOI: 10.1016/j.yexcr.2005.04.008  1
2005 von Mensdorff-Pouilly S, Kinarsky L, Engelmann K, Baldus SE, Verheijen RH, Hollingsworth MA, Pisarev V, Sherman S, Hanisch FG. Sequence-variant repeats of MUC1 show higher conformational flexibility, are less densely O-glycosylated and induce differential B lymphocyte responses. Glycobiology. 15: 735-46. PMID 15814824 DOI: 10.1093/glycob/cwi058  1
2005 Parry S, Sutton-Smith M, Heal P, Leir SH, Palmai-Pallag T, Morris HR, Hollingsworth MA, Dell A, Harris A. Evaluation of MUC6 mucin tandem repeats. Biochimica Et Biophysica Acta. 1722: 77-83. PMID 15716126 DOI: 10.1016/j.bbagen.2004.11.010  1
2005 Pisarev VM, Kinarsky L, Caffrey T, Hanisch FG, Sanderson S, Hollingsworth MA, Sherman S. T cells recognize PD(N/T)R motif common in a variable number of tandem repeat and degenerate repeat sequences of MUC1. International Immunopharmacology. 5: 315-30. PMID 15652762 DOI: 10.1016/j.intimp.2004.10.004  1
2005 Santos-Silva F, Fonseca A, Caffrey T, Carvalho F, Mesquita P, Reis C, Almeida R, David L, Hollingsworth MA. Thomsen-Friedenreich antigen expression in gastric carcinomas is associated with MUC1 mucin VNTR polymorphism. Glycobiology. 15: 511-7. PMID 15604091 DOI: 10.1093/glycob/cwi027  1
2004 Kohlgraf KG, Gawron AJ, Higashi M, VanLith ML, Shen X, Caffrey TC, Anderson JM, Hollingsworth MA. Tumor-specific immunity in MUC1.Tg mice induced by immunization with peptide vaccines from the cytoplasmic tail of CD227 (MUC1). Cancer Immunology, Immunotherapy : Cii. 53: 1068-84. PMID 15696607 DOI: 10.1007/S00262-004-0557-1  1
2004 Turnquist HR, Kohlgraf KG, McIlhaney MM, Mosley RL, Hollingsworth MA, Solheim JC. Tapasin decreases immune responsiveness to a model tumor antigen. Journal of Clinical Immunology. 24: 462-70. PMID 15163903 DOI: 10.1023/B:JOCI.0000029118.51587.d9  1
2004 Shibahara H, Tamada S, Goto M, Oda K, Nagino M, Nagasaka T, Batra SK, Hollingsworth MA, Imai K, Nimura Y, Yonezawa S. Pathologic features of mucin-producing bile duct tumors: two histopathologic categories as counterparts of pancreatic intraductal papillary-mucinous neoplasms. The American Journal of Surgical Pathology. 28: 327-38. PMID 15104295 DOI: 10.1097/00000478-200403000-00005  1
2004 Choudhury A, Moniaux N, Ulrich AB, Schmied BM, Standop J, Pour PM, Gendler SJ, Hollingsworth MA, Aubert JP, Batra SK. MUC4 mucin expression in human pancreatic tumours is affected by organ environment: the possible role of TGFbeta2. British Journal of Cancer. 90: 657-64. PMID 14760381 DOI: 10.1038/Sj.Bjc.6601604  1
2004 Shibahara H, Tamada S, Higashi M, Goto M, Batra SK, Hollingsworth MA, Imai K, Yonezawa S. MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type. Hepatology (Baltimore, Md.). 39: 220-9. PMID 14752841 DOI: 10.1002/Hep.20031  1
2004 Hollingsworth MA, Swanson BJ. Mucins in cancer: protection and control of the cell surface. Nature Reviews. Cancer. 4: 45-60. PMID 14681689 DOI: 10.1038/nrc1251  1
2004 Suryanarayanan G, Keifer PA, Wang G, Kinarsky L, Hollingsworth MA, Sherman S. NMR-based structural studies of the glycosylated MUC1 tandem repeat peptide International Journal of Molecular Sciences. 5: 84-92.  1
2003 Iacobuzio-Donahue CA, Ashfaq R, Maitra A, Adsay NV, Shen-Ong GL, Berg K, Hollingsworth MA, Cameron JL, Yeo CJ, Kern SE, Goggins M, Hruban RH. Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies. Cancer Research. 63: 8614-22. PMID 14695172  1
2003 Kohlgraf KG, Gawron AJ, Higashi M, Meza JL, Burdick MD, Kitajima S, Kelly DL, Caffrey TC, Hollingsworth MA. Contribution of the MUC1 tandem repeat and cytoplasmic tail to invasive and metastatic properties of a pancreatic cancer cell line. Cancer Research. 63: 5011-20. PMID 12941828  1
2003 Kinarsky L, Suryanarayanan G, Prakash O, Paulsen H, Clausen H, Hanisch FG, Hollingsworth MA, Sherman S. Conformational studies on the MUC1 tandem repeat glycopeptides: implication for the enzymatic O-glycosylation of the mucin protein core. Glycobiology. 13: 929-39. PMID 12925576 DOI: 10.1093/glycob/cwg109  1
2003 Wen Y, Caffrey TC, Wheelock MJ, Johnson KR, Hollingsworth MA. Nuclear association of the cytoplasmic tail of MUC1 and beta-catenin. The Journal of Biological Chemistry. 278: 38029-39. PMID 12832415 DOI: 10.1074/jbc.M304333200  1
2003 Mack DR, Ahrne S, Hyde L, Wei S, Hollingsworth MA. Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut. 52: 827-33. PMID 12740338 DOI: 10.1136/gut.52.6.827  1
2003 Silverman HS, Sutton-Smith M, McDermott K, Heal P, Leir SH, Morris HR, Hollingsworth MA, Dell A, Harris A. The contribution of tandem repeat number to the O-glycosylation of mucins. Glycobiology. 13: 265-77. PMID 12626424 DOI: 10.1093/glycob/cwg028  1
2002 VanLith ML, Kohlgraf KG, Sivinski CL, Tempero RM, Hollingsworth MA. MUC1-specific anti-tumor responses: molecular requirements for CD4-mediated responses. International Immunology. 14: 873-82. PMID 12147624  1
2002 Sivinski CL, Kohlgraf KG, VanLith ML, Morikane K, Tempero RM, Hollingsworth MA. Molecular requirements for CD8-mediated rejection of a MUC1-expressing pancreatic carcinoma: implications for tumor vaccines. Cancer Immunology, Immunotherapy : Cii. 51: 327-40. PMID 12111121 DOI: 10.1007/s00262-002-0277-3  1
2002 Swartz MJ, Batra SK, Varshney GC, Hollingsworth MA, Yeo CJ, Cameron JL, Wilentz RE, Hruban RH, Argani P. MUC4 expression increases progressively in pancreatic intraepithelial neoplasia. American Journal of Clinical Pathology. 117: 791-6. PMID 12090430 DOI: 10.1309/7Y7N-M1Wm-R0Yk-M2Va  1
2002 Shiraga T, Smith D, Nuthall HN, Hollingsworth MA, Harris A. Identification of two novel elements involved in human MUCI gene expression in vivo. Molecular Medicine (Cambridge, Mass.). 8: 33-41. PMID 11984004  1
2002 Iacobuzio-Donahue CA, Maitra A, Shen-Ong GL, van Heek T, Ashfaq R, Meyer R, Walter K, Berg K, Hollingsworth MA, Cameron JL, Yeo CJ, Kern SE, Goggins M, Hruban RH. Discovery of novel tumor markers of pancreatic cancer using global gene expression technology. The American Journal of Pathology. 160: 1239-49. PMID 11943709 DOI: 10.1016/S0002-9440(10)62551-5  1
2002 Schwientek T, Bennett EP, Flores C, Thacker J, Hollmann M, Reis CA, Behrens J, Mandel U, Keck B, Schäfer MA, Haselmann K, Zubarev R, Roepstorff P, Burchell JM, Taylor-Papadimitriou J, ... Hollingsworth MA, et al. Functional conservation of subfamilies of putative UDP-N-acetylgalactosamine:polypeptide N-acetylgalactosaminyltransferases in Drosophila, Caenorhabditis elegans, and mammals. One subfamily composed of l(2)35Aa is essential in Drosophila. The Journal of Biological Chemistry. 277: 22623-38. PMID 11925450 DOI: 10.1074/jbc.M202684200  1
2002 Ryu B, Jones J, Blades NJ, Parmigiani G, Hollingsworth MA, Hruban RH, Kern SE. Relationships and differentially expressed genes among pancreatic cancers examined by large-scale serial analysis of gene expression. Cancer Research. 62: 819-26. PMID 11830538  1
2002 Khorrami AM, Choudhury A, Andrianifahanana M, Varshney GC, Bhattacharyya SN, Hollingsworth MA, Kaufman B, Batra SK. Purification and characterization of a human pancreatic adenocarcinoma mucin. Journal of Biochemistry. 131: 21-9. PMID 11754731 DOI: 10.1093/Oxfordjournals.Jbchem.A003073  1
2001 Andrianifahanana M, Moniaux N, Schmied BM, Ringel J, Friess H, Hollingsworth MA, Büchler MW, Aubert JP, Batra SK. Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 7: 4033-40. PMID 11751498  1
2001 McDermott KM, Crocker PR, Harris A, Burdick MD, Hinoda Y, Hayashi T, Imai K, Hollingsworth MA. Overexpression of MUC1 reconfigures the binding properties of tumor cells. International Journal of Cancer. 94: 783-91. PMID 11745478 DOI: 10.1002/ijc.1554  1
2001 Silverman HS, Parry S, Sutton-Smith M, Burdick MD, McDermott K, Reid CJ, Batra SK, Morris HR, Hollingsworth MA, Dell A, Harris A. In vivo glycosylation of mucin tandem repeats. Glycobiology. 11: 459-71. PMID 11445551 DOI: 10.1093/Glycob/11.6.459  1
2001 Kern S, Hruban R, Hollingsworth MA, Brand R, Adrian TE, Jaffee E, Tempero MA. A white paper: The product of a pancreas cancer think tank Cancer Research. 61: 4923-4932. PMID 11406572  1
2001 Parry S, Silverman HS, McDermott K, Willis A, Hollingsworth MA, Harris A. Identification of MUC1 proteolytic cleavage sites in vivo Biochemical and Biophysical Research Communications. 283: 715-720. PMID 11341784 DOI: 10.1006/bbrc.2001.4775  1
2001 Ryu B, Jones J, Hollingsworth MA, Hruban RH, Kern SE. Invasion-specific genes in malignancy: Serial analysis of gene expression comparisons of primary and passaged cancers Cancer Research. 61: 1833-1838. PMID 11280733  1
2001 Morikane K, Tempero R, Sivinski CL, Kitajima S, Gendler SJ, Hollingsworth MA. Influence of organ site and tumor cell type on MUC1-specific tumor immunity. International Immunology. 13: 233-40. PMID 11157856  1
2000 Kitamura N, Iwamura T, Taniguchi S, Yamanari H, Kawano K, Hollingsworth MA, Setoguchi T. High collagenolytic activity in spontaneously highly metastatic variants derived from a human pancreatic cancer cell line (SUIT-2) in nude mice Clinical and Experimental Metastasis. 18: 561-571. PMID 11688961 DOI: 10.1023/A:1011900818419  1
2000 Kohsaki T, Nishimori I, Nakayama H, Miyazaki E, Enzan H, Nomoto M, Hollingsworth MA, Onishi S. Expression of UDP-GalNAc:Polypeptide N-acetylgalactosaminyltransferase isozymes T1 and T2 in human colorectal cancer Journal of Gastroenterology. 35: 840-848. PMID 11085493 DOI: 10.1007/s005350070021  1
2000 Satoh S, Hinoda Y, Hayashi T, Burdick MD, Imai K, Hollingsworth MA. Enhancement of metastatic properties of pancreatic cancer cells by MUC1 gene encoding an anti-adhesion molecule International Journal of Cancer. 88: 507-518. PMID 11058865 DOI: 10.1002/1097-0215(20001115)88:4<507::AID-IJC1>3.0.CO;2-0  1
2000 Kirnarsky L, Prakash O, Vogen SM, Nomoto M, Hollingsworth MA, Sherman S. Structural effects of O-glycosylation on a 15-residue peptide from the mucin (MUC1) core protein Biochemistry. 39: 12076-12082. PMID 11009623 DOI: 10.1021/bi0010120  1
2000 Hassan H, Reis CA, Bennett EP, Mirgorodskaya E, Roepstorff P, Hollingsworth MA, Burchell J, Taylor-Papadimitriou J, Clausen H. The lectin domain of UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-T4 directs its glycopeptide specificities. The Journal of Biological Chemistry. 275: 38197-205. PMID 10984485 DOI: 10.1074/jbc.M005783200  1
2000 Choudhury A, Moniaux N, Winpenny JP, Hollingsworth MA, Aubert JP, Batra SK. Human MUC4 mucin cDNA and its variants in pancreatic carcinoma Journal of Biochemistry. 128: 233-243. PMID 10920259 DOI: 10.1093/Oxfordjournals.Jbchem.A022746  1
1999 Bennett EP, Hassan H, Hollingsworth MA, Clausen H. A novel human UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase, GalNAc-T7, with specificity for partial GalNAc-glycosylated acceptor substrates. Febs Letters. 460: 226-30. PMID 10544240 DOI: 10.1016/S0014-5793(99)01268-5  1
1999 Hyde K, Harrison D, Hollingsworth MA, Harris A. Chloride-bicarbonate exchangers in the human fetal pancreas Biochemical and Biophysical Research Communications. 263: 315-321. PMID 10491290 DOI: 10.1006/bbrc.1999.1367  1
1999 Bennett EP, Hassan H, Mandel U, Hollingsworth MA, Akisawa N, Ikematsu Y, Merkx G, van Kessel AG, Olofsson S, Clausen H. Cloning and characterization of a close homologue of human UDP-N-acetyl-alpha-D-galactosamine:Polypeptide N-acetylgalactosaminyltransferase-T3, designated GalNAc-T6. Evidence for genetic but not functional redundancy. The Journal of Biological Chemistry. 274: 25362-70. PMID 10464263 DOI: 10.1074/jbc.274.36.25362  1
1999 Beum PV, Singh J, Burdick M, Hollingsworth MA, Cheng PW. Expression of core 2 beta-1,6-N-acetylglucosaminyltransferase in a human pancreatic cancer cell line results in altered expression of MUC1 tumor-associated epitopes. The Journal of Biological Chemistry. 274: 24641-8. PMID 10455130 DOI: 10.1074/jbc.274.35.24641  1
1999 Nishimori I, Kamakura M, Fujikawa-Adachi K, Nojima M, Onishi S, Hollingsworth MA, Harris A. Cholecystokinin A and B receptor mRNA expression in human pancreas Pancreas. 19: 109-113. PMID 10438155  1
1999 Hollingsworth MA. Proteins expressed by pancreatic duct cells and their relatives Annals of the New York Academy of Sciences. 880: 38-49. PMID 10415849 DOI: 10.1111/j.1749-6632.1999.tb09508.x  1
1999 Nishimori I, Fujikawa-Adachi K, Onishi S, Hollingsworth MA. Carbonic anhydrase in human pancreas: Hypotheses for the pathophysiological roles of CA isozymes Annals of the New York Academy of Sciences. 880: 5-16. PMID 10415846 DOI: 10.1111/j.1749-6632.1999.tb09505.x  1
1999 Akisawa N, Nishimori I, Iwamura T, Onishi S, Hollingsworth MA. High levels of ezrin expressed by human pancreatic adenocarcinoma cell lines with high metastatic potential Biochemical and Biophysical Research Communications. 258: 395-400. PMID 10329398 DOI: 10.1006/bbrc.1999.0653  1
1999 Fujikawa-Adachi K, Nishimori I, Sakamoto S, Morita M, Onishi S, Yonezawa S, Hollingsworth MA. Identification of carbonic anhydrase IV and VI mRNA expression in human pancreas and salivary glands Pancreas. 18: 329-335. PMID 10231836  1
1999 Mack DR, Michail S, Wei S, McDougall L, Hollingsworth MA. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression American Journal of Physiology - Gastrointestinal and Liver Physiology. 276: G941-G950. PMID 10198338  1
1999 Reid CJ, Burdick MD, Hollingsworth MA, Harris A. CFTR expression does not influence glycosylation of an epitope-tagged MUC1 mucin in colon carcinoma cell lines. Glycobiology. 9: 389-98. PMID 10089213  1
1999 Morikane K, Tempero RM, Sivinski CL, Nomoto M, Van Lith ML, Muto T, Hollingsworth MA. Organ-specific pancreatic tumor growth properties and tumor immunity. Cancer Immunology, Immunotherapy : Cii. 47: 287-96. PMID 10022473 DOI: 10.1007/s002620050533  1
1999 Schwientek T, Nomoto M, Levery SB, Merkx G, van Kessel AG, Bennett EP, Hollingsworth MA, Clausen H. Control of O-glycan branch formation. Molecular cloning of human cDNA encoding a novel beta1,6-N-acetylglucosaminyltransferase forming core 2 and core 4. The Journal of Biological Chemistry. 274: 4504-12. PMID 9988682 DOI: 10.1074/jbc.274.8.4504  1
1999 Tempero RM, Rowse GJ, Gendler SJ, Hollingsworth MA. Passively transferred anti-MUC1 antibodies cause neither autoimmune disorders nor immunity against transplanted tumors in MUC1 transgenic mice International Journal of Cancer. 80: 595-599. PMID 9935162 DOI: 10.1002/(SICI)1097-0215(19990209)80:4<595::AID-IJC18>3.0.CO;2-B  1
1999 Lohr M, Colcher D, Hollingsworth MA, Liebe S. Preface Annals of the New York Academy of Sciences. 880: XI-XII.  1
1998 Mack DR, Cheng PW, Perini F, Wei S, Hollingsworth MA. Altered expression of sialylated carbohydrate antigens in HT29 colonic carcinoma cells. Glycoconjugate Journal. 15: 1155-63. PMID 10372971 DOI: 10.1023/A:1006924208135  1
1998 Tempero RM, VanLith ML, Morikane K, Rowse GJ, Gendler SJ, Hollingsworth MA. CD4+ lymphocytes provide MUC1-specific tumor immunity in vivo that is undetectable in vitro and is absent in MUC1 transgenic mice. Journal of Immunology (Baltimore, Md. : 1950). 161: 5500-6. PMID 9820526  1
1998 Bennett EP, Hassan H, Mandel U, Mirgorodskaya E, Roepstorff P, Burchell J, Taylor-Papadimitriou J, Hollingsworth MA, Merkx G, van Kessel AG, Eiberg H, Steffensen R, Clausen H. Cloning of a human UDP-N-acetyl-alpha-D-Galactosamine:polypeptide N-acetylgalactosaminyltransferase that complements other GalNAc-transferases in complete O-glycosylation of the MUC1 tandem repeat. The Journal of Biological Chemistry. 273: 30472-81. PMID 9804815 DOI: 10.1074/jbc.273.46.30472  1
1998 Kirnarsky L, Nomoto M, Ikematsu Y, Hassan H, Bennett EP, Cerny RL, Clausen H, Hollingsworth MA, Sherman S. Structural analysis of peptide substrates for mucin-type O-glycosylation. Biochemistry. 37: 12811-7. PMID 9737858 DOI: 10.1021/bi981034a  1
1998 Sharma P, Dudus L, Nielsen PA, Clausen H, Yankaskas JR, Hollingsworth MA, Engelhardt JF. MUC5B and MUC7 are differentially expressed in mucous and serous cells of submucosal glands in human bronchial airways American Journal of Respiratory Cell and Molecular Biology. 19: 30-37. PMID 9651178 DOI: 10.1165/Ajrcmb.19.1.3054  1
1998 Amado M, Almeida R, Carneiro F, Levery SB, Holmes EH, Nomoto M, Hollingsworth MA, Hassan H, Schwientek T, Nielsen PA, Bennett EP, Clausen H. A family of human beta3-galactosyltransferases. Characterization of four members of a UDP-galactose:beta-N-acetyl-glucosamine/beta-nacetyl-galactosamine beta-1,3-galactosyltransferase family. The Journal of Biological Chemistry. 273: 12770-8. PMID 9582303 DOI: 10.1074/jbc.273.21.12770  1
1998 Göttke MU, Keller K, Belley A, Garcia RM, Hollingsworth MA, Mack DR, Chadee K. Functional heterogeneity of colonic adenocarcinoma mucins for inhibition of Entamoeba histolytica adherence to target cells. The Journal of Eukaryotic Microbiology. 45: 17S-23S. PMID 9561779 DOI: 10.1111/J.1550-7408.1998.Tb04519.X  1
1998 Winpenny JP, Harris A, Hollingsworth MA, Argent BE, Gray MA. Calcium-activated chloride-conductance in a pancreatic adenocarcinoma cell line of ductal origin (HPAF) and in freshly isolated human pancreatic duct cells Pflugers Archiv European Journal of Physiology. 435: 796-803. PMID 9518508 DOI: 10.1007/s004240050586  1
1998 Rowse GJ, Tempero RM, VanLith ML, Hollingsworth MA, Gendler SJ. Tolerance and immunity to MUC1 in a human MUC1 transgenic murine model. Cancer Research. 58: 315-21. PMID 9443411  1
1998 VanLith ML, Tempero RM, Gendler SJ, Hollingsworth MA. In vitro kinetic analysis of cellular anti-MUC1 immune responses in MUC1 transgenic mice Faseb Journal. 12: A891.  1
1998 Tempero RM, Morikane K, Vanlith ML, Gendler SJ, Hollingsworth MA. Tolerance and immunity to MUC1 in a human MUC1 transgenic murine model Faseb Journal. 12: A891.  1
1997 Ikematsu Y, Liu G, Fienhold MA, Cano M, Adrian TE, Hollingsworth MA, Williamson JE, Sanger W, Tomioka T, Pour PM. In vitro pancreatic ductal cell carcinogenesis. International Journal of Cancer. Journal International Du Cancer. 72: 1095-103. PMID 9378545 DOI: 10.1002/(SICI)1097-0215(19970917)72:6<1095::AID-IJC26>3.0.CO;2-2  1
1997 Sutherlin ME, Nishimori I, Caffrey T, Bennett EP, Hassan H, Mandel U, Mack D, Iwamura T, Clausen H, Hollingsworth MA. Expression of three UDP-N-acetyl-alpha-D-galactosamine:polypeptide GalNAc N-acetylgalactosaminyltransferases in adenocarcinoma cell lines. Cancer Research. 57: 4744-8. PMID 9354435  1
1997 Burdick MD, Harris A, Reid CJ, Iwamura T, Hollingsworth MA. Oligosaccharides expressed on MUC1 produced by pancreatic and colon tumor cell lines Journal of Biological Chemistry. 272: 24198-24202. PMID 9305871 DOI: 10.1074/jbc.272.39.24198  1
1997 Wandall HH, Hassan H, Mirgorodskaya E, Kristensen AK, Roepstorff P, Bennett EP, Nielsen PA, Hollingsworth MA, Burchell J, Taylor-Papadimitriou J, Clausen H. Substrate specificities of three members of the human UDP-N-acetyl-alpha-D-galactosamine:Polypeptide N-acetylgalactosaminyltransferase family, GalNAc-T1, -T2, and -T3. The Journal of Biological Chemistry. 272: 23503-14. PMID 9295285 DOI: 10.1074/jbc.272.38.23503  1
1997 Hyde K, Reid CJ, Tebbutt SJ, Weide L, Hollingsworth MA, Harris A. The cystic fibrosis transmembrane conductance regulator as a marker of human pancreatic duct development Gastroenterology. 113: 914-919. PMID 9287984 DOI: 10.1016/S0016-5085(97)70187-2  1
1997 Iwamura T, Caffrey TC, Kitamura N, Yamanari H, Setoguchi T, Hollingsworth MA. P-selectin expression in a metastatic pancreatic tumor cell line (SUIT- 2) Cancer Research. 57: 1206-1212. PMID 9067294  1
1997 Yonezawa S, Sueyoshi K, Nomoto M, Kitamura H, Nagata K, Arimura Y, Tanaka S, Hollingsworth MA, Siddiki B, Kim YS, Sato E. MUC2 gene expression is found in noninvasive tumors but not in invasive tumors of the pancreas and liver: Its close relationship with prognosis of the patients Human Pathology. 28: 344-352. PMID 9042800 DOI: 10.1016/S0046-8177(97)90134-9  1
1997 Tempero RM, Hollingsworth MA, Burdick MD, Finch AM, Taylor SM, Vogen SM, Morgan EL, Sanderson SD. Molecular adjuvant effects of a conformationally biased agonist of human C5a anaphylatoxin. Journal of Immunology (Baltimore, Md. : 1950). 158: 1377-82. PMID 9013982  1
1997 McKie AB, Iwamura T, Leung HY, Hollingsworth MA, Lemoine NR. Alu-polymerase chain reaction genomic fingerprinting technique identifies multiple genetic loci associated with pancreatic tumourigenesis Genes Chromosomes and Cancer. 18: 30-41. PMID 8993978 DOI: 10.1002/(SICI)1098-2264(199701)18:1<30::AID-GCC4>3.0.CO;2-2  1
1996 Pahwa GS, James Maher L, Hollingsworth MA. A potential H-DNA element in the MUC1 promoter does not influence transcription Journal of Biological Chemistry. 271: 26543-26546. PMID 8900124 DOI: 10.1074/jbc.271.43.26543  1
1996 Hudson MJ, Stamp GW, Hollingsworth MA, Pignatelli M, Lalani EN. MUC1 expressed in PanC1 cells decreases adhesion to type 1 collagen but increases contraction in collagen lattices. The American Journal of Pathology. 148: 951-60. PMID 8774149  1
1996 Nelson KL, Becker NA, Pahwa GS, Hollingsworth MA, Maher LJ. Potential for H-DNA in the human MUC1 mucin gene promoter Journal of Biological Chemistry. 271: 18061-18067. PMID 8663482 DOI: 10.1074/jbc.271.30.18061  1
1996 Smith AN, Barth ML, McDowell TL, Moulin DS, Nuthall HN, Hollingsworth MA, Harris A. A regulatory element in intron 1 of the cystic fibrosis transmembrane conductance regulator gene. The Journal of Biological Chemistry. 271: 9947-54. PMID 8626632 DOI: 10.1074/jbc.271.17.9947  1
1996 Kino-Ohsaki J, Nishimori I, Morita M, Okazaki K, Yamamoto Y, Onishi S, Hollingsworth MA. Serum antibodies to carbonic anhydrase I and II in patients with idiopathic chronic pancreatitis and Sjogren's syndrome Gastroenterology. 110: 1579-1586. PMID 8613065 DOI: 10.1053/gast.1996.v110.pm8613065  1
1995 Toshkov IA, Chaney WG, Colcher DM, Hollingsworth MA, Bratanova TK, Perini F, Pour PM. A novel adhesion factor produced by hamster pancreatic cancer cell line is effective on normal and carcinoma cell lines of different species. International Journal of Pancreatology : Official Journal of the International Association of Pancreatology. 18: 249-55. PMID 8708397 DOI: 10.1007/BF02784949  1
1995 Nishimori I, Bratanova T, Toshkov I, Caffrey T, Mogaki M, Shibata Y, Hollingsworth MA. Induction of experimental autoimmune sialoadenitis by immunization of PL/J mice with carbonic anhydrase II Journal of Immunology. 154: 4865-4873. PMID 7722336  1
1994 Nishimori I, Johnson NR, Sanderson SD, Perini F, Mountjoy K, Cerny RL, Gross ML, Hollingsworth MA. Influence of acceptor substrate primary amino acid sequence on the activity of human UDP-N-acetylgalactosamine:Polypeptide N-Acetylgalactosaminyltransferase: Studies with the MUC1 tandem repeat Journal of Biological Chemistry. 269: 16123-16130. PMID 8206912  1
1994 Hollingsworth MA, Strawhecker JM, Caffreyi TC, Mack DR. Expression of MUC1, MUC2, MUC3 and MUC4 mucin mrnas in human pancreatic and intestinal tumor cell lines International Journal of Cancer. 57: 198-203. PMID 8157358  1
1994 Mack DR, Hollingsworth MA. Alteration in Expression of MUC2 and MUC3 mRNA Levels in HT29 Colonic Carcinoma Cells Biochemical and Biophysical Research Communications. 199: 1012-1018. PMID 8135773 DOI: 10.1006/bbrc.1994.1330  1
1994 Nishimori I, Cerny RL, Fontenot JD, Perini F, Gross ML, Moun KP, Sanderson SD, Johnson N, Hollingsworth MA. N-Acetylgalactosamine Glycosylation of MUC1 Tandem Repeat Peptides by Pancreatic Tumor Cell Extracts Cancer Research. 54: 3738-3744. PMID 8033093  1
1994 McDonald CD, Hollingsworth MA, Maher LJ. Enzymatic and chemical probing of an S1 nuclease-sensitive site upstream from the human CFTR gene Gene. 150: 267-274. PMID 7529740 DOI: 10.1016/0378-1119(94)90436-7  1
1994 Chambers JA, Hollingsworth MA, Trezise AEO, Harris A. Developmental expression of mucin genes MUC1 and MUC2 Journal of Cell Science. 107: 413-424. PMID 7515892  1
1994 Hollingsworth MA, Closken C, Harris A, Mcdonald CD, Pahwa GS, Maher LJ. A nuclear factor that binds purine-rich, single-stranded oligonucleotides derived from S1-sensitive elements upstream of the CFTR gene and the MUC1 gene Nucleic Acids Research. 22: 1138-1146. PMID 7513081 DOI: 10.1093/nar/22.7.1138  1
1994 Hollingsworth MA. Markers for detecting early pancreatic cancer: Summary International Journal of Pancreatology. 16: 305-307.  1
1994 Hollingsworth MA. Posttranslational processing of MUC1 by pancreatic tumors International Journal of Pancreatology. 16: 258-259.  1
1993 Vishwanatha JK, Chiang Y, Kumble KD, Hollingsworth MA, Pour PM. Enhanced expression of annexin II in human pancreatic carcinoma cells and primary pancreatic cancers Carcinogenesis. 14: 2575-2579. PMID 8269629 DOI: 10.1093/carcin/14.12.2575  1
1992 Batra SK, Metzgar RS, Hollingsworth MA. Human muc 1 mucin gene expression in the fetal pancreas Pancreas. 7: 391-393. PMID 1594562 DOI: 10.1097/00006676-199205000-00018  1
1992 Hollingsworth MA, Batra SK, Qi WN, Yankaskas JR. MUC1 mucin mRNA expression in cultured human nasal and bronchial epithelial cells American Journal of Respiratory Cell and Molecular Biology. 6: 516-520. PMID 1581075 DOI: 10.1165/Ajrcmb/6.5.516  1
1992 Batra SK, Metzgar RS, Worlock AJ, Hollingsworth MA. Expression of the human MUC1 mucin cDNA in a hamster pancreatic tumor cell line HP-1 International Journal of Pancreatology. 12: 271-283. PMID 1289420 DOI: 10.1007/Bf02924367  1
1991 Batra SK, Metzgar RS, Hollingsworth MA. Molecular cloning and sequence analysis of the human ribosomal protein S16 Journal of Biological Chemistry. 266: 6830-6833. PMID 2016298  1
1991 Batra SK, Metzgar RS, Hollingsworth MA. A simple, effective method for the construction of subtracted cDNA libraries Genetic Analysis Techniques and Applications. 8: 129-133. PMID 1878262 DOI: 10.1016/1050-3862(91)90029-Q  1
1991 Batra SK, Kern HF, Worlock AJ, Metzgar RS, Hollingsworth MA. Transfection of the human Muc 1 mucin gene into a poorly differentiated human pancreatic tumor cell line, Panc1: Integration, expression and ultrastructural changes Journal of Cell Science. 100: 841-849. PMID 1814933  1
1991 Batra SK, Metzgar RS, Hollingsworth MA. Isolation and characterization of a complementary DNA (PD-1) differentially expressed by human pancreatic ductal cell tumors Cell Growth & Differentiation : the Molecular Biology Journal of the American Association For Cancer Research. 2: 385-390. PMID 1793733  1
1991 Batra SK, Hollingsworth MA. Expression of the human mucin gene, Muc 1, in normal tissues and metastatic pancreatic tumors International Journal of Pancreatology. 10: 287-292. PMID 1787340 DOI: 10.1007/Bf02924167  1
1990 Lan MS, Batra SK, Qi WN, Metzgar RS, Hollingsworth MA. Cloning and sequencing of a human pancreatic tumor mucin cDNA Journal of Biological Chemistry. 265: 15294-15299. PMID 2394722  1
1990 Hollingsworth MA, Borowitz MJ, Everett ML, Metzgar RS. A Novel Ribonucleoprotein Complex Defined by Monoclonal Antibodies to NIH 3T3 Cells Transfected with Human Pancreatic Adenocarcinoma DNA Cancer Research. 50: 6015-6022. PMID 2393865  1
1990 Lan MS, Hollingsworth MA, Metzgar RS. Polypeptide Core of a Human Pancreatic Tumor Mucin Antigen Cancer Research. 50: 2997-3001. PMID 2334903  1
1989 Metzgar RS, Lan MS, Kim YW, Koriwchak MJ, Mullins TD, Hollingsworth MA. DU-PAN-2, mucin type differentiation antigen of normal and malignant pancreatic ductal cells Progress in Clinical and Biological Research. 288: 53-61. PMID 2717641  1
1986 Hollingsworth MA, Rebellato LM, Moore JW, Finn OJ, Metzgar RS. Antigens expressed on NIH 3T3 cells following transformation with DNA from human pancreatic tumor. Cancer Research. 46: 2482-7. PMID 3697988  1
1984 Hollingsworth MA, Evans DL. Helper factor(s) generated by tumor-immune rats for lymphoproliferative responses to syngeneic tumor cells Journal of the National Cancer Institute. 72: 1357-1363. PMID 6233443 DOI: 10.1093/jnci/72.6.1357  1
1984 Hogan KT, Hollingsworth MA, Seymour RE, Quinn MK, Evans DL. Suppression of polyclonal, tumor cell and alloantigen-induced proliferation: Identification of cycloxygenase pathway dependent and independent mechanisms Immunopharmacology. 7: 49-57. PMID 6232242 DOI: 10.1016/0162-3109(84)90007-9  1
1983 Sterchi JM, Evans DL, Hollingsworth MA, Brown JJ, Mutton TP, Chung M. Evaluation of technique for autotransplantation of the spleen in dogs American Surgeon. 49: 625-631. PMID 6638704  1
1983 Hollingsworth MA, Evans DL. Changes in spleen cell proliferative responses and resistance to syngeneic tumor challenge in aging NBR rats Mechanisms of Ageing and Development. 22: 321-333. PMID 6226837 DOI: 10.1016/0047-6374(83)90086-6  1
1982 Hollingsworth MA, Evans DL. Differences in spleen suppressor cell content in rats with progressing and regressing tumors Journal of the National Cancer Institute. 69: 53-58. PMID 6212710  1
1981 Hollingsworth MA, Barrowclough J, Evans DL. Age-related increases in mitogenic responses and natural immunity to a syngeneic fibrosarcoma in rats Mechanisms of Ageing and Development. 17: 95-106. PMID 7311620 DOI: 10.1016/0047-6374(81)90129-9  1
Show low-probability matches.